Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Aug 20, 2012 · 10-Q · 51 days after period end · 0001471242-12-001163
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$1.56M | — |
| EPS Diluted | -$0.09 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 20, 2012 · 51 d after period end
